Overview
Ryuichi Murase practices practicing medicine in Toon, Japan.
His clinical expertise encompasses Salivary Gland Tumors, Oral Squamous Cell Carcinoma, and Adenoid Cystic Carcinoma.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryuichi Murase
Is Ryuichi Murase a top-rated expert for Salivary Gland Tumors?
MediFind is an objective health platform that identifies experts based on real-world data. Ryuichi Murase is classified as an Experienced expert for Salivary Gland Tumors, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryuichi Murase participate in research or clinical trials?
Yes. Ryuichi Murase has published 10 articles and abstracts on conditions like Salivary Gland Tumors. You can view a list of Ryuichi Murase's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adenoid Cystic CarcinomaMr. Murase isExperienced. Learn about Adenoid Cystic Carcinoma.
- Oral Squamous Cell CarcinomaMr. Murase isExperienced. Learn about Oral Squamous Cell Carcinoma.
- Salivary Gland TumorsMr. Murase isExperienced. Learn about Salivary Gland Tumors.